Preventive Effect of Halofuginone on Concanavalin A-Induced Liver Fibrosis

Halofuginone (HF) is an active component of extracts derived from the plant alkaloid febrifugine and has shown therapeutic promise in animal models of fibrotic disease. Our main objectives were to clarify the suppressive effect of HF on concanavalin A (ConA)-induced liver fibrosis. ConA injection in...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jie, Zhang, Bei, Shen, Ruo-wu, Liu, Jia-Bao, Gao, Mei-hua, Li, Ying, Li, Yuan-Yuan, Zhang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864948/
https://www.ncbi.nlm.nih.gov/pubmed/24358159
http://dx.doi.org/10.1371/journal.pone.0082232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864948/
https://www.ncbi.nlm.nih.gov/pubmed/24358159
http://dx.doi.org/10.1371/journal.pone.0082232

Ejemplares similares